Back to Media Room
 
Malaysian Business, 11 Feb 2008

Nanotechnology – an invisible giant

By Dr Brian O’keeffe & Wan Amir Jeffery Majid

Nature has developed “nanotechnologies” over billions of years, employing enzymes catalysts to organize, with exquisite precision, different kind of atoms and molecules into complex microscopic structures that make life possible. Many researchers are trying very hard to emulate nature. The work that researchers in the industrial, agriculture, healthcare and ICT spheres are aimed at producing and commercializing better optical fibres, pesticides, drug delivery system, energy, paints and surface coating, ect that would simply become better overall products.

In the healthcare industry, nanotechnology is an exciting and important enabler. The biological and medical research communication are using nanotechnology to produce nanoparticles, nanomaterials and nanorobotics, to develop new products and processes in drug discovery, diagnostics and imaging, just to name a few. All these uses are known as nanomedicine.

The impact of nanotechnology on fields such as diagnostics, drug delivery and tissue engineering is immense. Nanotechnology on a chip is creating great interest. It is one more dimension of lab on a chip technology.

In drug delivery the use of nanoparticles and molecular carries enables to achieve solubility, leading to better absorption. Drug may be contained within a molecular carrier, either to protect them from stomach acids or to control the release of the drug to a specific targeted area, reducing the likelihood of side effects. Such drugs are already beginning pre-clinical or clinical trials, adhering to the strict regulatory requirements for new pharmaceuticals.

Targeted or personalized medicines reduce drug consumption and treatment expenses resulting in an overall societal by reducing the costs to the public health system. Nanotechnology is also opening up new opportunities in implantable delivery system, which are often preferable to the use of inject able drug, because the latter frequently display first order kinetics.

Nanotechnology can also help to reproduce or to repair damaged tissue. This so called “tissue engineering” makes use of artificially stimulated cell proliferation by using suitable nanomaterial based scaffolds and growth factors. Tissue engineering might replace today’s conventional treatments for example organ transplants or artificial implants. Such technologies can be used to regulate in vitro cellular microenvironment to direct stem cell differentiation.

As the nanomedicine industry continues to grow, it is expected to have a significant impact on the world from economic and societal well being perspectives. From the applications such drug delivery and in vivo imaging to the potential machines of the future, advancements in nanomedicine are being made every day. It will not belong for the billon dollar industry to explode a hundred-fold with current applications only the beginning.

Rise of Asia
Asian countries are investing significantly in nanotechnology, and may already surpass the U.S in this promising area of research. China has been investing heavily in nanotechnology and already leads the U.S in some key areas. For example, Chinese scientists at Beijing’s Tsinghua University announced that they have significantly increased the rate at which carbon nanotubes can be produced. The scientists say they have developed new approach carbon nanotubes at 15 kilograms per hour, 60 times faster than the speed at which US scientists had been producing them.

Although there has been much hype about the potential applications of nanotechnology, most current commercialized applications are limited to the use of “first generation” passive nanomaterials. Further applications which require actual manipulation or arrangement of nanoscale components await further research.

However, the potential for nanotechnology to become an important tool for the development of healthcare, industrial and agricultural industries cannot be denied. Progress in research is being made in many quarters and the potential of nanotechnology being the next IT wave is too high to be ignored.

Malaysian recognizes this fact, and the government has, through the Malaysian Biotechnology Corporation’s (BiotechCorp) technology acquisition program, acquired the world-wide exclusive licensing right to a non-cancer application of a nanoparticles technology from a company based in France. With access to this platform technology, Malaysian researchers can now undertake research programs that can be commercialized to produce product in 23 applications identified so far. This is a hugely significant technology that, if utilized to its maximum potential, has the ability to change the landscape of Malaysia’s R&D for the better.

With nanotechnology; industries would be able to produce innovative, better and valuable products for healthcare, agriculture and industrial sectors. Importantly, these products would be produced cost-efficiently.

However, much of what is believe to be achievable through the use of nanotechnology remains speculative. But if nanotechnology, at maturity, achieves even a fraction of its promise, its impact and significance economies and markets cannot be ignored.
Home | Biotech In Malaysia | About Us | One Stop Centre | The BioNexus Network | Grants & Programmes | Events |
Media Room
| Contact Us | Useful Links | Disclaimer